ACIP |
Advisory Committee on Immunization Practices
|
IIS |
Immunization Information Systems |
Anti-FHA |
Antibody directed against filamentous hemagglutinin
|
IPV |
Inactivated poliovirus vaccine |
Anti-FIM |
Antibody directed against fimbrial proteins |
IM |
intramuscularly |
Anti-PRN |
Antibody directed against pertactin |
IOM |
Institute of Medicine |
Anti-PT |
Antibody directed against pertussis toxin |
IU |
international units |
CI |
confidence interval |
Lf |
limit of flocculation unit |
CSTE |
Council of State and Territorial Epidemiologists
|
MCV4 |
Quadrivalent meningococcal conjugate vaccine |
DFA |
direct fluorescent antibody |
mL |
Milliliter |
DT |
pediatric diphtheria and tetanus toxoids vaccine
|
NNDSS |
National Notifiable Disease surveillance System |
DTaP |
pediatric diphtheria and tetanus toxoids
and acellular pertussis vaccine |
PCR |
polymerase chain reaction |
DTP |
pediatric diphtheria and tetanus toxoids
and whole-cell pertussis vaccine |
PRN |
pertactin, 69kDa protein |
ELISA |
Enzyme-linked immunoabsorbant assay |
PPD |
tuberculin purified protein derivative |
FDA |
Food and Drug Administration |
PT |
pertussis toxin, lymphocytosis promoting factor |
FHA |
filamentous hemagglutinin |
Tdap |
adult tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine |
FIM |
Fimbriae |
Td |
adult tetanus and reduced diphtheria toxoids vaccine |
GMC |
geometric mean antibody concentration |
TIG |
tetanus immune globulin |
Hep |
B Hepatitis B vaccine |
TIV |
trivalent inactivated influenza vaccine |
Hib |
Haemophilus influenzae type b |
TT |
tetanus toxoid vaccine |
|
|
VAERS |
Vaccine Adverse Event Reporting System |
|
|
VICP |
Vaccine Injury Compensation Program |
|
|
WHO |
World Health Organization |